KRBL adds a new variety to its India Gate portfolio
KRBL adds a new variety to its India Gate portfolio

KRBL adds a new variety to its India Gate portfolio

DSIJ Intelligence Article rating: 3.7

KRBL is the company known for its world-renowned brand 'India Gate' for premium Basmati rice. The company recently launched ‘India Gate Rice Flour’ thus, adding to its diversified product portfolio. 

Break the 10 per cent retirement planning rule
Break the 10 per cent retirement planning rule

Break the 10 per cent retirement planning rule

DSIJ Intelligence Article rating: 3.5

Not all rules are meant to be broken as they may dent your pocket heavily. However, in this article, we would be explaining why you should break the 10 per cent retirement planning rule.

Reliance share zooms on joining hands with BP to set up second new deepwater gas field
Reliance share zooms on joining hands with BP to set up second new deepwater gas field

Reliance share zooms on joining hands with BP to set up second new deepwater gas field

DSIJ Intelligence Article rating: 3.7

Reliance Industries Limited (RIL) informed today that it has collaborated with BP, one of the world's seven oil & gas ‘supermajors’ and British multinational company to commence production from the Satellite Cluster Gas Field in block KG D6, off the east coast of India.  

Biocon Biologics and its partner Viatris get EC nod for biosimilar Bevacizumab
Biocon Biologics and its partner Viatris get EC nod for biosimilar Bevacizumab

Biocon Biologics and its partner Viatris get EC nod for biosimilar Bevacizumab

Apurva Joshi Article rating: 5.0

Biocon Limited’s subsidiary Biocon Biologics Ltd has informed the bourses that Abevmy 100 & 400 mg, a biosimilar of Bevacizumab co-developed with Viatris Inc. has received marketing authorisation approval from European Commission (EC), following the positive recommendation by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency. 

Natco Pharma seeks emergency nod for its COVID-19 capsules; rises over 6 per cent
Natco Pharma seeks emergency nod for its COVID-19 capsules; rises over 6 per cent

Natco Pharma seeks emergency nod for its COVID-19 capsules; rises over 6 per cent

Abhinav Lahoti Article rating: 3.8

The company today announced that it has applied to Central Drugs Standard Control Organisation (CDSCO) of India for the approval of phase 3 clinical trials of ‘Molnupiravir’ capsules, which have shown promising results during the treatment of COVID-19 positive patient. 

In conversation with Mahesh Patil, Chief Investment Officer of Aditya Birla Sun Life AMC Ltd
In conversation with Mahesh Patil, Chief Investment Officer of Aditya Birla Sun Life AMC Ltd

In conversation with Mahesh Patil, Chief Investment Officer of Aditya Birla Sun Life AMC Ltd

DSIJ Intelligence Article rating: 3.7

We follow a ‘growth at a reasonable price (GARP) investing style’ since it combines the best of both worlds. We have identified themes that provide secular growth opportunities such as private banks, unorganised to organised, speciality chemicals, manufacturing in India, and technology/digital.

RSS
First25912592259325942596259825992600Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR